402 related articles for article (PubMed ID: 9500552)
21. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions.
Schrader CE; Vardo J; Stavnezer J
J Exp Med; 2002 Feb; 195(3):367-73. PubMed ID: 11828012
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite instability in human solid tumors.
Lothe RA
Mol Med Today; 1997 Feb; 3(2):61-8. PubMed ID: 9060003
[TBL] [Abstract][Full Text] [Related]
23. Tumor-associated Apc mutations in Mlh1-/- Apc1638N mice reveal a mutational signature of Mlh1 deficiency.
Kuraguchi M; Edelmann W; Yang K; Lipkin M; Kucherlapati R; Brown AM
Oncogene; 2000 Nov; 19(50):5755-63. PubMed ID: 11126362
[TBL] [Abstract][Full Text] [Related]
24. Multiple mutations are common at mouse Aprt in genotoxin-exposed mismatch repair deficient cells.
Shin CY; Mellon I; Turker MS
Oncogene; 2002 Mar; 21(11):1768-76. PubMed ID: 11896608
[TBL] [Abstract][Full Text] [Related]
25. Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability.
Ma AH; Xia L; Littman SJ; Swinler S; Lader G; Polinkovsky A; Olechnowicz J; Kasturi L; Lutterbaugh J; Modrich P; Veigl ML; Markowitz SD; Sedwick WD
Oncogene; 2000 Apr; 19(18):2249-56. PubMed ID: 10822375
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.
Wei Q; Bondy ML; Mao L; Gaun Y; Cheng L; Cunningham J; Fan Y; Bruner JM; Yung WK; Levin VA; Kyritsis AP
Cancer Res; 1997 May; 57(9):1673-7. PubMed ID: 9135006
[TBL] [Abstract][Full Text] [Related]
27. Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain.
Ellison AR; Lofing J; Bitter GA
Nucleic Acids Res; 2004; 32(18):5321-38. PubMed ID: 15475387
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo.
Sansom OJ; Bishop SM; Court H; Dudley S; Liskay RM; Clarke AR
DNA Repair (Amst); 2003 Sep; 2(9):1029-39. PubMed ID: 12967659
[TBL] [Abstract][Full Text] [Related]
29. Lack of PMS2 gene-truncating mutations in patients with hereditary colorectal cancer.
Viel A; Novella E; Genuardi M; Capozzi E; Fornasarig M; Pedroni M; Santarosa M; De Leon MP; Della Puppa L; Anti M; Boiocchi M
Int J Oncol; 1998 Sep; 13(3):565-9. PubMed ID: 9683794
[TBL] [Abstract][Full Text] [Related]
30. Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer.
Teruya-Feldstein J; Greene J; Cohen L; Popplewell L; Ellis NA; Offit K
Leuk Lymphoma; 2002 Aug; 43(8):1619-26. PubMed ID: 12400605
[TBL] [Abstract][Full Text] [Related]
31. Expression of DNA mismatch repair genes in naevi.
Korabiowska M; Brinck U; Ruschenburg I; Dengler H; Droese M; Berger H
In Vivo; 1999; 13(3):251-4. PubMed ID: 10459502
[TBL] [Abstract][Full Text] [Related]
32. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.
Xicola RM; Llor X; Pons E; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Duque JM; Nicolás-Pérez D; Garcia AM; Rigau J; Gassull MA;
J Natl Cancer Inst; 2007 Feb; 99(3):244-52. PubMed ID: 17284719
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors.
Senba S; Konishi F; Okamoto T; Kashiwagi H; Kanazawa K; Miyaki M; Konishi M; Tsukamoto T
Cancer; 1998 Jan; 82(2):279-85. PubMed ID: 9445183
[TBL] [Abstract][Full Text] [Related]
34. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key.
Leong V; Lorenowicz J; Kozij N; Guarné A
Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896
[TBL] [Abstract][Full Text] [Related]
35. Evidence for involvement of yeast proliferating cell nuclear antigen in DNA mismatch repair.
Johnson RE; Kovvali GK; Guzder SN; Amin NS; Holm C; Habraken Y; Sung P; Prakash L; Prakash S
J Biol Chem; 1996 Nov; 271(45):27987-90. PubMed ID: 8910404
[TBL] [Abstract][Full Text] [Related]
36. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
[TBL] [Abstract][Full Text] [Related]
38. Mlh1 can function in antibody class switch recombination independently of Msh2.
Schrader CE; Vardo J; Stavnezer J
J Exp Med; 2003 May; 197(10):1377-83. PubMed ID: 12743174
[TBL] [Abstract][Full Text] [Related]
39. Visualization of mosaicism in tissues of normal and mismatch-repair-deficient mice carrying a microsatellite-containing transgene.
Hersh MN; Stambrook PJ; Stringer JR
Mutat Res; 2002 Aug; 505(1-2):51-62. PubMed ID: 12175905
[TBL] [Abstract][Full Text] [Related]
40. Relationship between DNA mismatch repair genes expression, Ku-genes expression and ploidy-related parameters in the progression of pigmented lesions of the skin.
Korabiowska M; Tscherny M; Stachura J; Ruschenburg I; Cordon-Cardo C; Brinck U
In Vivo; 2002; 16(5):317-21. PubMed ID: 12494870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]